Machine Learning-Based Time-Series Clustering Identifies Archetypal Trajectories of Hematotoxicity after CAR T-Cell Therapy
Jordan Gauthier(Seattle Cancer Care Alliance), Damian J. Green(Sylvester Comprehensive Cancer Center), Joshua A. Hill(Fred Hutch Cancer Center), Erik L. Kimble(University of Washington), David G. Maloney(Fred Hutch Cancer Center), Rahul Banerjee(University of Washington), Andrew J. Cowan(University of Washington Medical Center), Aiko Torkelson(Fred Hutch Cancer Center), Qian Wu(Cancer Research Center), Andrew J. Portuguese(University of Washington), Aude G. Chapuis(University of Washington), Brian G. Till(University of Washington), Alexandre V. Hirayama(University of Washington), Mazyar Shadman(University of Washington), Delaney Kirchmeier(Fred Hutch Cancer Center), Christina Poh(University of Washington), Filippo Milano(Fred Hutch Cancer Center), Lorenzo Iovino(University of Pisa), Folashade Otegbeye(University Hospitals of Cleveland), Aya Albittar(University of Washington), Ryan D. Cassaday(University of Washington), Abigail Chutnik(Fred Hutch Cancer Center), Nikki Pin(Fred Hutch Cancer Center), Joseph De Los Reyes(Fred Hutch Cancer Center), Jennifer J. Huang(Stanford Medicine), Ajay K. Gopal(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Barbara Pender(Fred Hutch Cancer Center)
Cited by 0
Related Papers
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
Global Burden of Multiple Myeloma
|JAMA Oncology|2018|631